Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,500 results for ""SYMPTOMATIC Parkinson's disease""

Your Filters

Geographic : united states
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Periodical

MONTHS PAST APRIL.

Subjects: *PARKINSON'S disease; *VINEYARDS; *APHIDSUNITED StatesPARKINSON, James; CHARCOT, J. M. (Jean Martin), 1825-1893

  • Source: History Today. Apr2022, Vol. 72 Issue 4, p26-27. 2p.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Adult and in utero exposure to cocaine alters sensitivity to the parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Subjects: *COCAINE abuse; *SYMPTOMATIC Parkinson's disease; *SYNAPSESUNITED States

  • Source: Neuroscience. Apr2006, Vol. 137 Issue 3, p905-913. 9p.

Record details

Read More Add to Saved list
×
Academic Journal

Hearing Loss, Incident Parkinson Disease, and Treatment With Hearing Aids.

  • Authors : Neilson LE; Department of Neurology, Oregon Health & Science University, Portland.; Neurology and Research Service, VA Portland Health Care System, Portland, Oregon.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/epidemiology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/therapy ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/complications

  • Source: JAMA neurology [JAMA Neurol] 2024 Dec 01; Vol. 81 (12), pp. 1295-1303.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589536 Publication Model: Print

Record details

Read More Add to Saved list
×
Academic Journal

Sodium-glucose cotransporter 2 inhibitors and the risk of Parkinson disease in real-world patients with type 2 diabetes.

  • Authors : Guo J; Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.; Tang H

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Dec; Vol. 26 (12), pp. 5727-5736. Date of Electronic Publication: 2024 Sep 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

"It just makes you more vulnerable as an employee": Understanding the effects of disability stigma on employment in Parkinson's disease.

  • Authors : Carolan K; School of Social Work, University of Connecticut, Hartford, CT, USA.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/psychology ; Social Stigma* ; Employment*/Employment*/Employment*/psychology

  • Source: Chronic illness [Chronic Illn] 2024 Dec; Vol. 20 (4), pp. 655-668. Date of Electronic Publication: 2023 Jul 04.Publisher: Sage Publications Country of Publication: United States NLM ID: 101253019 Publication Model: Print-Electronic

Record details

Read More Add to Saved list
×
Academic Journal

Glucagon-Like Peptide-1 Receptor Agonists and Risk of Parkinson's Disease in Patients with Type 2 Diabetes: A Population-Based Cohort Study.

  • Authors : Tang H; Department of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, Gainesville, Florida, USA.; Lu Y

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/epidemiology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2024 Nov; Vol. 39 (11), pp. 1960-1970. Date of Electronic Publication: 2024 Aug 27.Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The association between brominated flame retardants exposure with Parkinson's disease in US adults: a cross-sectional study of the National Health and Nutrition Examination Survey 2009-2016.

  • Authors : Lv JJ; Department of Vascular Surgery, Shanghai Putuo People's Hospital, School of Medicine, Tongji University, Shanghai, China.; Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, Shanghai, China.

Subjects: Flame Retardants* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/blood ; Nutrition Surveys*

  • Source: Frontiers in public health [Front Public Health] 2024 Oct 21; Vol. 12, pp. 1451686. Date of Electronic Publication: 2024 Oct 21 (Print Publication: 2024).Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocol.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/genetics ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/ethnology ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/epidemiology

  • Source: BMC neurology [BMC Neurol] 2024 Oct 21; Vol. 24 (1), pp. 403. Date of Electronic Publication: 2024 Oct 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100968555 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2377

Record details

Read Online Read More Add to Saved list
×
Editorial & Opinion

Author Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries.

Subjects: Medicare* ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/epidemiology ; Particulate Matter*/Particulate Matter*/Particulate Matter*/adverse effects

  • Source: Neurology [Neurology] 2024 Oct 08; Vol. 103 (7), pp. e209412. Date of Electronic Publication: 2024 Sep 10.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model:

Record details

Read More Add to Saved list
×
Editorial & Opinion

Reader Response: Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries.

Subjects: Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/epidemiology ; Medicare* ; Particulate Matter*/Particulate Matter*/Particulate Matter*/adverse effects

  • Source: Neurology [Neurology] 2024 Oct 08; Vol. 103 (7), pp. e209374. Date of Electronic Publication: 2024 Sep 10.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,500 results for ""SYMPTOMATIC Parkinson's disease""